BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27158366)

  • 1. BRD7: a novel tumor suppressor gene in different cancers.
    Yu X; Li Z; Shen J
    Am J Transl Res; 2016; 8(2):742-8. PubMed ID: 27158366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
    J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.
    Liu Y; Zhao R; Wang H; Luo Y; Wang X; Niu W; Zhou Y; Wen Q; Fan S; Li X; Xiong W; Ma J; Li X; Tan M; Li G; Zhou M
    Cell Death Dis; 2016 Mar; 7(3):e2156. PubMed ID: 27010857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.
    Wu M; Li X; Li X; Li G
    Curr Genomics; 2009 Jun; 10(4):216-22. PubMed ID: 19949542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.
    Park YA; Lee JW; Kim HS; Lee YY; Kim TJ; Choi CH; Choi JJ; Jeon HK; Cho YJ; Ryu JY; Kim BG; Bae DS
    Clin Cancer Res; 2014 Feb; 20(3):565-75. PubMed ID: 24198243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRD7 Stabilizes P53 via Dephosphorylation of MDM2 to Inhibit Tumor Growth in Breast Cancer Harboring Wild-type P53.
    Luo Y; Wang X; Niu W; Zhou Y; Li M; Ma J; Yang J; Fan S; Zeng Z; Xiong W; Li X; Li G; Xiao J; Zhou M
    J Cancer; 2022; 13(5):1436-1448. PubMed ID: 35371302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer.
    Niu W; Luo Y; Wang X; Zhou Y; Li H; Wang H; Fu Y; Liu S; Yin S; Li J; Zhao R; Liu Y; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Tan M; Zhou M
    Cell Death Dis; 2018 May; 9(5):519. PubMed ID: 29725006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
    Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
    Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRD7 inhibits tumor progression by positively regulating the p53 pathway in hepatocellular carcinoma.
    Chen CL; Mo HQ; Jiang YH; Zhao XH; Ma S; You KY; Pan Y; Liu YM
    J Cancer; 2021; 12(5):1507-1519. PubMed ID: 33531996
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.
    Zhou M; Liu H; Xu X; Zhou H; Li X; Peng C; Shen S; Xiong W; Ma J; Zeng Z; Fang S; Nie X; Yang Y; Zhou J; Xiang J; Cao L; Peng S; Li S; Li G
    J Cell Biochem; 2006 Jul; 98(4):920-30. PubMed ID: 16475162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming Stimulated Clone 22 (TSC-22) Interacts Directly with Bromodomain-Containing Protein 7 (BRD7) to Enhance the Inhibition of Extracellular Signal-Regulate Kinase (ERK) Pathway in Ovarian Cancer.
    Lee SH; Choi D
    Dev Reprod; 2022 Sep; 26(3):117-126. PubMed ID: 36285148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.
    Liu Y; Zhao R; Wei Y; Li M; Wang H; Niu W; Zhou Y; Qiu Y; Fan S; Zhan Y; Xiong W; Zhou Y; Li X; Li Z; Li G; Zhou M
    J Exp Clin Cancer Res; 2018 Mar; 37(1):64. PubMed ID: 29559001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.
    Peng C; Zhou J; Liu HY; Zhou M; Wang LL; Zhang QH; Yang YX; Xiong W; Shen SR; Li XL; Li GY
    J Cell Biochem; 2006 Mar; 97(4):882-92. PubMed ID: 16265664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.
    Zhang XM; Wang XY; Sheng SR; Wang JR; Li J
    World J Gastroenterol; 2003 Aug; 9(8):1729-33. PubMed ID: 12918109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene regulation and tumor suppression by the bromodomain-containing protein BRD7.
    Mantovani F; Drost J; Voorhoeve PM; Del Sal G; Agami R
    Cell Cycle; 2010 Jul; 9(14):2777-81. PubMed ID: 20647772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.
    Chen CL; Wang Y; Pan QZ; Tang Y; Wang QJ; Pan K; Huang LX; He J; Zhao JJ; Jiang SS; Zhang XF; Zhang HX; Zhou ZQ; Weng de S; Xia JC
    Oncotarget; 2016 Mar; 7(13):16248-61. PubMed ID: 26919247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.
    Balasubramanian A; Subramaniam R; Narayanan V; Annamalai T; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1615-9. PubMed ID: 25743841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the BRD7 gene promoter.
    Liu H; Peng C; Zhou M; Zhou J; Shen S; Zhou H; Xiong W; Luo X; Peng S; Niu Z; Ouyang J; Li X; Li G
    DNA Cell Biol; 2006 Jun; 25(6):346-58. PubMed ID: 16792505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Researching a novel NPC-related candidate suppressor gene BRD7 by two-dimensional gel electrophoresis and MALDI-TOF-MS].
    Peng C; Liang SP; Tan C; Lv HB; Huang H; Zhou M; Wang R; Li XL; Li GY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):816-22. PubMed ID: 12958654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.